Organicell Regenerative Medicine: Funding & Investors (Sep 2026)
Organicell Regenerative Medicine is an exosome therapeutics organization with an emphasis on growing new biologic medication. It is driven by a mission is to change regenerative medication by proceeding to consolidate exosome innovation with other synergistic treatments and become the medical services innovation hatchery for biologic medication. The organization was established in 2014 and is settled in Miami, Florida.
Organicell Regenerative Medicine has raised $4.0M across 1 funding round on record, the most recent a Post-IPO Equity of $4.0M announced in Jul 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Organicell Regenerative Medicine Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Organicell Regenerative Medicine Funding Rounds
Organicell Regenerative Medicine Founders and Leadership Team
Contact details for the Organicell Regenerative Medicine team: 1 of 1 has an email address on file.
Start 14-day free trial →Organicell Regenerative Medicine Funding Compared to Other Biotechnology Startups
Organicell Regenerative Medicine's latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Organicell Regenerative Medicine in Biotechnology and Miami
Companies Similar to Organicell Regenerative Medicine
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Organicell Regenerative Medicine Funding FAQs
What does Organicell Regenerative Medicine do?
Organicell Regenerative Medicine is an exosome therapeutics organization with an emphasis on growing new biologic medication. It is driven by a mission is to change regenerative medication by proceeding to consolidate exosome innovation with other synergistic treatments and become the medical services innovation hatchery for biologic medication. The organization was established in 2014 and is settled in Miami, Florida.
How much funding has Organicell Regenerative Medicine raised?
Organicell Regenerative Medicine has raised $4.0M across 1 round on record. The most recent is a Post-IPO Equity of $4.0M announced in Jul 2022.
When did Organicell Regenerative Medicine last raise funding?
Organicell Regenerative Medicine's most recent funding round on record is a Post-IPO Equity of $4.0M, announced in Jul 2022.
Who is the CEO of Organicell Regenerative Medicine?
Albert Mitrani is listed as CEO at Organicell Regenerative Medicine.
Where is Organicell Regenerative Medicine headquartered?
Organicell Regenerative Medicine is based in Miami, Florida, United States.
How many employees does Organicell Regenerative Medicine have?
Organicell Regenerative Medicine is in the 11-50 employee band.
How does Organicell Regenerative Medicine's funding compare to other Biotechnology startups?
Organicell Regenerative Medicine's latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Organicell Regenerative Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Organicell Regenerative Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.